$1.110
+0.042 (+3.74%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
SNOA-Prognose durch Analyse ähnlicher Charts
Alphio's SNOA stock price prediction model matches the current Sonoma Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.13 (+1.40%). The 1-week path is $1.14 (+2.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Sonoma Pharmaceuticals Inc-Aktien kaufen?
Sonoma Pharmaceuticals Inc (SNOA) appears to be a good buy right now due to its recent FDA clearance for the Microdacyn Wound Solution, which is expected to enhance market competitiveness. The stock is currently priced at $1.11, significantly below its 52-week high of $3.95, indicating potential for upside. Additionally, the company reported a 48.3% year-over-year revenue increase in Q4 2026, reaching $5.56 million, which reflects a strong recovery trend. However, a key risk is the forward P/E ratio of 46.08, suggesting that the stock may be overvalued relative to its earnings potential.
SNOA schloss am Friday bei $1.11, nachdem der Kurs +3.74% gestiegen ist
Sonoma Pharmaceuticals Inc (SNOA) last closed at $1.11, gaining +3.74%. These facts feed the 1-day and 1-week SNOA price prediction above.
Analystenkonsens
Sonoma Pharmaceuticals Inc (SNOA): 2 Kaufen, 0 Halten, 0 Verkaufen. Ausblick: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Sonoma Pharmaceuticals Inc (SNOA) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf SNOA am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für SNOA
Historically the probability of a positive November return for SNOA is 43.18%. July offers the highest probability of a positive month at 66.67%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-Jahres-Kursprojektionen für SNOA
| Monat | Tiefstkurs | Ø-Kurs | Höchstkurs | Potenzieller ROI |
|---|---|---|---|---|
| Nov 2026 | $3.30 | $3.86 | $4.03 | +248.19% |
| Dec 2026 | $3.78 | $4.08 | $4.90 | +267.80% |
Für 2026 wird für Sonoma Pharmaceuticals Inc (SNOA) eine Spanne von $3.30 bis $4.90 projiziert.
Monatsprognose 2026 für Sonoma Pharmaceuticals Inc
Im Nov 2026 wird für Sonoma Pharmaceuticals Inc ein Durchschnitt von $3.86 erwartet, mit einem Tief von $3.30 und einem Hoch von $4.03.
Im Dec 2026 wird für Sonoma Pharmaceuticals Inc ein Durchschnitt von $4.08 erwartet, mit einem Tief von $3.78 und einem Hoch von $4.90.
Ähnliche Artikel
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.